While MYBL2 High lung adenocarcinomas show evidence of elevated MMEJ, it is worth pointing out that these are conservative estimates observed at the genome-wide level and the actual level of genomic alterations facilitated by dysregulated MMEJ would be predicted to be even higher. This evidence concerns the gene MYBL2 and lung adenocarcinoma.